| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Haemonetics wins FDA nod for expanded vascular closure system use | ||
| Mo | Rocket Lab receives approval to acquire Mynaric in April | ||
| Mo | IMAX CEO takes medical leave for pneumonia treatment | ||
| Mo | Vicarious Surgical completes testing of surgical instrument suite | ||
| Mo | M&T Bank authorizes $5 billion stock buyback program | ||
| Mo | Scorpio Tankers to sell two product tankers for $70 million | ||
| Mo | Kennedy-Wilson terminates bond exchange offer | ||
| Mo | BTIG reiterates Buy on Apogee Therapeutics stock, $137 target | ||
| Mo | PepGen reports mixed results from DM1 trial, 10mg cohort ongoing | ||
| Mo | Service Properties Trust launches $500M share offering | ||
| Mo | Genasys appoints Larry Hagenbuch to board as audit chair | ||
| Mo | ARRAY Technologies opens new APA Solar headquarters in Ohio | ||
| Mo | Air Lease receives final approval for Sumitomo merger | ||
| Mo | Nutriband selects brand name for fentanyl patch, submits to FDA | ||
| Mo | RCI Hospitality receives Nasdaq extension to file quarterly report | ||
| Mo | AEON Biopharma reports biosimilar progress, secures financing | ||
| Mo | Pathfinder Bancorp declares $0.10 quarterly dividend | ||
| Mo | INmune Bio reports $45.9M loss, plans UK regulatory filing | ||
| Mo | Palisade Bio reports Phase 1b trial results for Crohn's drug | ||
| Mo | FDA clears Aktis Oncology's AKY-2519 for phase 1b trial | ||
| Mo | Inogen names new CFO, CMO in leadership reshuffle | ||
| Mo | Vertiv invests $50M to expand Ohio manufacturing capacity | ||
| Mo | Goosehead Insurance names Martin Thornthwaite general counsel | ||
| Mo | B-Parts partners with Klarna for flexible payment options | ||
| Mo | Mizuho reiterates Eikon Therapeutics stock rating on pipeline update |